- Home
- IQV vs GEHC Comparison
IQV vs GEHC Comparison
Compare IQV & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IQV
- GEHC
- Stock Information
- Founded
- IQV 1982
- GEHC 1892
- Country
- IQV United States
- GEHC United States
- Employees
- IQV N/A
- GEHC N/A
- Industry
- IQV Biotechnology: Commercial Physical & Biological Resarch
- GEHC Computer Software: Prepackaged Software
- Sector
- IQV Health Care
- GEHC Technology
- Exchange
- IQV Nasdaq
- GEHC Nasdaq
- Market Cap
- IQV 31.6B
- GEHC 37.5B
- IPO Year
- IQV 2013
- GEHC N/A
- Fundamental
- Price
- IQV $177.31
- GEHC $80.01
- Analyst Decision
- IQV Strong Buy
- GEHC Buy
- Analyst Count
- IQV 18
- GEHC 12
- Target Price
- IQV $248.72
- GEHC $98.75
- AVG Volume (30 Days)
- IQV 1.5M
- GEHC 3.4M
- Earning Date
- IQV 05-01-2025
- GEHC 04-29-2025
- Dividend Yield
- IQV N/A
- GEHC 0.17%
- EPS Growth
- IQV 2.74
- GEHC 43.17
- EPS
- IQV 7.49
- GEHC 4.34
- Revenue
- IQV $15,405,000,000.00
- GEHC $19,672,000,000.00
- Revenue This Year
- IQV $4.30
- GEHC $3.65
- Revenue Next Year
- IQV $6.17
- GEHC $4.63
- P/E Ratio
- IQV $23.68
- GEHC $18.44
- Revenue Growth
- IQV 2.81
- GEHC 0.61
- 52 Week Low
- IQV $176.03
- GEHC $74.51
- 52 Week High
- IQV $253.84
- GEHC $94.80
- Technical
- Relative Strength Index (RSI)
- IQV 35.22
- GEHC 33.71
- Support Level
- IQV $180.00
- GEHC $80.49
- Resistance Level
- IQV $188.39
- GEHC $82.89
- Average True Range (ATR)
- IQV 4.58
- GEHC 1.88
- MACD
- IQV -0.35
- GEHC -0.17
- Stochastic Oscillator
- IQV 9.22
- GEHC 2.38
About IQV IQVIA Holdings Inc.
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
About GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).